SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008975
Filing Date
2022-05-10
Accepted
2022-05-10 16:11:52
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cala-20220331.htm   iXBRL 10-Q 2318757
2 EX-31.1 cala-ex31_1.htm EX-31.1 16055
3 EX-31.2 cala-ex31_2.htm EX-31.2 15624
4 EX-32.1 cala-ex32_1.htm EX-32.1 11166
5 EX-32.2 cala-ex32_2.htm EX-32.2 11065
  Complete submission text file 0000950170-22-008975.txt   7522105

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cala-20220331_lab.xml EX-101.LAB 419534
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cala-20220331_pre.xml EX-101.PRE 308689
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cala-20220331_cal.xml EX-101.CAL 34411
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cala-20220331.xsd EX-101.SCH 50382
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cala-20220331_def.xml EX-101.DEF 157160
60 EXTRACTED XBRL INSTANCE DOCUMENT cala-20220331_htm.xml XML 1215176
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 22909725
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences